For research designs examining the intersection of metabolic and inflammatory biology, KPV provides a small-peptide anti-inflammatory research tool that operates through fundamentally different mechanisms than the incretin family compounds
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
GLP-1 Receptors Exist Throughout the Body Although GLP-1 medications work in the pancreas to regulate insulin and glucagon, GLP-1 receptors are widely distributed in other areas of the body, including the brain, cardiovascular system, immune system, gut, and kidneys, says Diana Isaacs, PharmD, CDCES, an endocrine clinical pharmacy specialist in the Endocrine and Metabolism Institute at Cleveland Clinic in Ohio
GLP-1 receptor agonists mimic naturally-occurring hormones that signal fullness to the brain and slow emptying in the gut